| FSELX | KTCIX | FSELX / KTCIX | |
| Total Expense Ratio | 0.62 | 0.68 | 91% |
| Annual Report Gross Expense Ratio | 0.62 | 0.68 | 91% |
| Fund Existence | 40 years | 23 years | - |
| Gain YTD | 35.704 | 19.059 | 187% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 29.3B | 2.17B | 1,349% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 31.27 | 10.78 | 290% |
| Returns for 3 years | 180.41 | 101.84 | 177% |
| Returns for 5 years | 201.10 | 51.64 | 389% |
| Returns for 10 years | 476.80 | 195.78 | 244% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ACVDX | 11.36 | -0.04 | -0.35% |
| American Century International Val R6 | |||
| JFNNX | 80.85 | -0.42 | -0.52% |
| Janus Henderson Global Life Sciences N | |||
| CSIIX | 8.69 | -0.06 | -0.69% |
| Copeland International Small Cap I | |||
| LICRX | 18.09 | -0.22 | -1.20% |
| Lord Abbett International Equity R3 | |||
| OSTFX | 20.58 | -0.30 | -1.44% |
| Osterweis | |||